Skip to content

Avanos Medical AVNS Changes in unrecognized tax benefits

Changes in unrecognized tax benefits at other companies

AMN Healthcare logo
AMN HealthcareAMN
-2.2%-4.7pp
Baxter International logo
Baxter InternationalBAX
-48.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
2.7%+2.1pp
Henry Schein logo
Henry ScheinHSIC
0.7%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies.

The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's changes in unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's changes in unrecognized tax benefits?
Avanos Medical (AVNS) reported changes in unrecognized tax benefits of 0% in Q4 2025.
What does changes in unrecognized tax benefits mean?
Reflects the impact of changes in unrecognized tax benefits on the company's effective tax rate. It quantifies how adjustments to tax contingencies influence the overall tax burden relative to statutory rates.